A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targets
V. Palande, R. Detroja, A. Gorohovski, R. Glass, C. Flueh, M. Kurtz, S. Perez, D. Raviv Shay, T. Siegal, M. Frenkel-Morgenstern
This study identifies gene-gene fusions in glioma patients using cfDNA from plasma, showing potential as diagnostic biomarkers and drug targets for precision medicine.
bioRxiv · Feb 25, 2020 · PreprintCancer Biology